# Study EHR Risk Stratification Tools

Study · id `cardio:ct-nct06995378` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06995378](<https://clinicaltrials.gov/study/NCT06995378>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06995378

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1200 participants.

## Technical summary

Registry record NCT06995378. Randomized; no masking; primary purpose health services research. Start 2026-05-27 (actual); primary completion 2026-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose health services research
- Phase: Not applicable
- Enrolled: 1200 participants (planned count; ClinicalTrials.gov record NCT06995378, source copy `cardio:ctgov-nct06995378-2026-07-09`, retrieved 2026-11-18)
- Started: 2026-05-27 (actual) (ClinicalTrials.gov record NCT06995378, source copy `cardio:ctgov-nct06995378-2026-07-09`, retrieved 2026-11-18)
- Primary completion: 2026-11 (anticipated) (ClinicalTrials.gov record NCT06995378, source copy `cardio:ctgov-nct06995378-2026-07-09`, retrieved 2026-11-18)
- Completion: 2029-09 (anticipated) (ClinicalTrials.gov record NCT06995378, source copy `cardio:ctgov-nct06995378-2026-07-09`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT06995378, source copy `cardio:ctgov-nct06995378-2026-07-09`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06995378-2026-07-09`, retrieved 2026-11-18)

## The registry's words

- Brief title: Study EHR Risk Stratification Tools
- Condition: Prediabetes
- Condition: Health Communication
- Condition: Patient Comprehension
- Intervention (Device): Hemoglobin A1c Lab Result Communication Tool
- Lead sponsor: University of California, Los Angeles
- Lead sponsor class: OTHER
- Collaborator: National Institute on Aging (NIA)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Prediabetes (`cardio:prediabetes`)
- Registry lists this organization as the lead sponsor: University of California, Los Angeles (`cardio:org-university-of-california-los-angeles`)
- Registry lists this organization as a collaborator: National Institute on Aging (`cardio:nia`)

## Provenance

Content hash: 7f2e47b56775a6574c91b95666c0de855e37d95109d5c40d5d095d9264c604ec
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
